期刊
OPEN BIOLOGY
卷 6, 期 8, 页码 -出版社
ROYAL SOC
DOI: 10.1098/rsob.160134
关键词
apoptosis; spindle checkpoint; paclitaxel; taxol; WEHI-539
资金
- Cancer Research UK
- University of Manchester
- Wellcome Trust
- Medical Research Council [MR/L006839/1]
- Cancer Research UK [19842, 11913] Funding Source: researchfish
- Medical Research Council [MR/L006839/1] Funding Source: researchfish
- MRC [MR/L006839/1] Funding Source: UKRI
Cell fate in response to an aberrant mitosis is governed by two competing networks: the spindle assembly checkpoint (SAC) and the intrinsic apoptosis pathway. The mechanistic interplay between these two networks is obscured by functional redundancy and the ability of cells to die either in mitosis or in the subsequent interphase. By coupling time-lapse microscopy with selective pharmacological agents, we systematically probe pro-survival Bcl-xL in response to various mitotic perturbations. Concentration matrices show that BH3-mimetic-mediated inhibition of Bcl-xL synergises with perturbations that induce an SAC-mediated mitotic block, including drugs that dampen microtubule dynamics, and inhibitors targeting kinesins and kinases required for spindle assembly. By contrast, Bcl-xL inhibition does not synergize with drugs which drive cells through an aberrant mitosis by overriding the SAC. This differential effect, which is explained by compensatory Mcl-1 function, provides opportunities for patient stratification and combination treatments in the context of cancer chemotherapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据